Insider filing · ACAD
Laura Brege
Director
profile →
ACADIA Pharmaceuticals Inc.
ACAD · Healthcare · 12 filings in 24 months
ticker →
Laura Brege sold $315K of ACADIA Pharmaceuticals (ACAD)
Executed Jun 4 2025, disclosed Jun 5 2025, 1 day later.
Value, as filed
$315K
14,446 sh × $21.78
Executed
Jun 4 2025
the trade date, as filed
Disclosed
Jun 5 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LBLaura Brege (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $1.3M of MIRM (17,000 sh across 2 lots, as filed), executed Sep 11 2025.
The name
ACADHealthcare · ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological an…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→